13,700 Shares in Aspen Aerogels, Inc. (NYSE:ASPN) Bought by SG Americas Securities LLC

SG Americas Securities LLC acquired a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 13,700 shares of the construction company’s stock, valued at approximately $379,000.

Several other hedge funds also recently added to or reduced their stakes in ASPN. Banque Cantonale Vaudoise grew its position in shares of Aspen Aerogels by 37.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after acquiring an additional 1,252 shares in the last quarter. Harbour Capital Advisors LLC bought a new stake in Aspen Aerogels during the first quarter valued at $404,000. Bridgewater Advisors Inc. acquired a new stake in shares of Aspen Aerogels during the first quarter worth $750,000. BNP Paribas Financial Markets lifted its position in shares of Aspen Aerogels by 85.2% in the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after buying an additional 11,823 shares during the last quarter. Finally, GSA Capital Partners LLP acquired a new position in shares of Aspen Aerogels in the 1st quarter valued at about $1,181,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Performance

ASPN stock opened at $21.60 on Friday. The company has a 50-day simple moving average of $26.00 and a 200 day simple moving average of $24.35. The company has a market capitalization of $1.64 billion, a P/E ratio of -49.08 and a beta of 2.16. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. Aspen Aerogels, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $33.15.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The business had revenue of $117.80 million during the quarter, compared to analysts’ expectations of $101.99 million. During the same period last year, the firm posted ($0.22) earnings per share. The business’s revenue was up 144.4% on a year-over-year basis. Sell-side analysts predict that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. HC Wainwright reiterated a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday. Roth Mkm reissued a “buy” rating and issued a $36.00 price target on shares of Aspen Aerogels in a report on Wednesday, August 21st. Barclays assumed coverage on Aspen Aerogels in a research report on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price objective for the company. B. Riley raised Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th. Finally, Benchmark reissued a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $29.70.

Insider Buying and Selling at Aspen Aerogels

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Donald R. Young sold 63,355 shares of the stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by corporate insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.